Gene therapy for pediatric AIDS

Annals of the New York Academy of Sciences

Volumn 918, Issue , 2000, Pages 318-329

  Bauer, G ^a   Selander, D ^a   Engel, B ^a   Carbonaro, D ^a   Csik, S ^a   Rawlings, S ^a   Church, J ^a   Kohn, D B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; BONE MARROW CELL; CASE REPORT; CHILD; CONFERENCE PAPER; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRINAE; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0033635758     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05501.x     Document Type: Conference Paper

References (29)

1. Intracellular immunization
2. Functional dissection of the HIV-1-1 rev trans-activator-derivation of a trans-dominant repressor of rev function
3. Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients
4. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes
5. Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits HIV-1 replication in the myelomonocytic cells produced in long-term culture
6. Anti-HIV-1 hammerhead ribozymes transduced by retroviral vectors inhibit HIV-1 replication in human T lymphocytes
7. Inhibition of HIV-1 replication after transduction of G-CSF-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes
8. A clinical trial of retroviral-mediated transfer of an RRE decoy gene into CD34+ cells from the bone marrow of HIV-1 infected children
9. Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemia
10. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation
11. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates
12. Multiple modifications in cis-elements of the LTR of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma (EC) cells
13. Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells
14. Improved expression in murine hematopoietic and lymphoid cells after transplantation of bone marrow transduced with a modified retroviral vector
15. Versatile retroviral vectors for potential use in gene therapy
16. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors
17. Inhibition of HIV-1 by a double transdominant fusion gene
18. Immune response to green fluorescent protein: Implications for gene therapy
19. Gene therapy using hematopoietic stem cells
20. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
21. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability
22. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor
23. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
24. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1 based lentiviral vectors
25. Efficient transduction of human CD34+ cells that mediaste long-term engraftment of NOD/SCID mice by HIV vectors
26. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells
27. 1 human hematopoietic stem cells
28. Development of a self-inactivating lentivirus vector
29. A third-generation lentivirus vector with a conditional packaging system